...
rvph-img

Reviva Pharmaceuticals Holdings Inc., Common Stock

RVPH

NAQ

$1.546

+$0.15

(10.71%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$46.82M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
895.73K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.06
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.6 L
$5.67 H
$1.546

About Reviva Pharmaceuticals Holdings Inc., Common Stock

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of various neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention"deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. Reviva Pharmaceuticals Holdings, Inc. was founded in 2018 and is headquartered in Cupertino, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameRVPHSectorS&P500
1-Week Return-44.44%-3.39%0.2%
1-Month Return10.24%-1.92%2.72%
3-Month Return9.37%-10.54%7.31%
6-Month Return-3.45%-4.47%10.44%
1-Year Return-60.67%4.06%27.53%
3-Year Return-51.56%0.94%30.88%
5-Year Return-86.62%36.67%89.21%
10-Year Return-85.58%102.87%199.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue-724.74K---[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit-(724.74K)---[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-72474000,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses376.86K2.43M10.10M24.31M39.50T[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(376.86K)(2.43M)(10.10M)(24.31M)(39.50T)[{"date":"2019-12-31","value":-37686000,"profit":false},{"date":"2020-12-31","value":-243465100,"profit":false},{"date":"2021-12-31","value":-1010451300,"profit":false},{"date":"2022-12-31","value":-2430660800,"profit":false},{"date":"2023-12-31","value":-3950363600000000,"profit":false}]
Total Non-Operating Income/Expense(938.34K)(2.70M)1.59M170.90K39.50T[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(846.03K)(3.78M)(8.52M)(24.32M)(39.24M)[{"date":"2019-12-31","value":-84603200,"profit":false},{"date":"2020-12-31","value":-378258800,"profit":false},{"date":"2021-12-31","value":-851587200,"profit":false},{"date":"2022-12-31","value":-2431851500,"profit":false},{"date":"2023-12-31","value":-3924388800,"profit":false}]
Income Taxes800.00800.006.00K20.78K(16.95B)[{"date":"2019-12-31","value":3.85,"profit":true},{"date":"2020-12-31","value":3.85,"profit":true},{"date":"2021-12-31","value":28.9,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-81575780.91,"profit":false}]
Income After Taxes(846.83K)(3.78M)(8.52M)(24.34M)16.91B[{"date":"2019-12-31","value":-0.01,"profit":false},{"date":"2020-12-31","value":-0.02,"profit":false},{"date":"2021-12-31","value":-0.05,"profit":false},{"date":"2022-12-31","value":-0.14,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Continuous Operations(846.83K)(3.78M)(8.52M)(24.34M)(39.26M)[{"date":"2019-12-31","value":-84683200,"profit":false},{"date":"2020-12-31","value":-378338800,"profit":false},{"date":"2021-12-31","value":-852187600,"profit":false},{"date":"2022-12-31","value":-2433929200,"profit":false},{"date":"2023-12-31","value":-3926083700,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(846.83K)(3.78M)(8.52M)(24.34M)(39.26T)[{"date":"2019-12-31","value":-84683200,"profit":false},{"date":"2020-12-31","value":-378338800,"profit":false},{"date":"2021-12-31","value":-852187600,"profit":false},{"date":"2022-12-31","value":-2433929200,"profit":false},{"date":"2023-12-31","value":-3926083700000000,"profit":false}]
EPS (Diluted)0.42(0.31)(0.56)(1.25)(1.64)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-73.81,"profit":false},{"date":"2021-12-31","value":-133.33,"profit":false},{"date":"2022-12-31","value":-297.62,"profit":false},{"date":"2023-12-31","value":-390.48,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

RVPH
Cash Ratio 0.32
Current Ratio 0.39

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

RVPH
ROA (LTM) -233.95%
ROE (LTM) -1795.06%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

RVPH
Debt Ratio Lower is generally better. Negative is bad. 2.31
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -1.31

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

RVPH
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 8.35
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Reviva Pharmaceuticals Holdings Inc. share price today?

Reviva Pharmaceuticals Holdings Inc. (RVPH) share price today is $1.546

Can Indians buy Reviva Pharmaceuticals Holdings Inc. shares?

Yes, Indians can buy shares of Reviva Pharmaceuticals Holdings Inc. (RVPH) on Vested. To buy Reviva Pharmaceuticals Holdings Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RVPH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Reviva Pharmaceuticals Holdings Inc. be purchased?

Yes, you can purchase fractional shares of Reviva Pharmaceuticals Holdings Inc. (RVPH) via the Vested app. You can start investing in Reviva Pharmaceuticals Holdings Inc. (RVPH) with a minimum investment of $1.

How to invest in Reviva Pharmaceuticals Holdings Inc. shares from India?

You can invest in shares of Reviva Pharmaceuticals Holdings Inc. (RVPH) via Vested in three simple steps:

  • Click on Sign Up or Invest in RVPH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Reviva Pharmaceuticals Holdings Inc. shares
What is Reviva Pharmaceuticals Holdings Inc. 52-week high and low stock price?

The 52-week high price of Reviva Pharmaceuticals Holdings Inc. (RVPH) is $5.67. The 52-week low price of Reviva Pharmaceuticals Holdings Inc. (RVPH) is $0.6.

What is Reviva Pharmaceuticals Holdings Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Reviva Pharmaceuticals Holdings Inc. (RVPH) is

What is Reviva Pharmaceuticals Holdings Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Reviva Pharmaceuticals Holdings Inc. (RVPH) is 8.35

What is Reviva Pharmaceuticals Holdings Inc. dividend yield?

The dividend yield of Reviva Pharmaceuticals Holdings Inc. (RVPH) is 0.00%

What is the Market Cap of Reviva Pharmaceuticals Holdings Inc.?

The market capitalization of Reviva Pharmaceuticals Holdings Inc. (RVPH) is $46.82M

What is Reviva Pharmaceuticals Holdings Inc.’s stock symbol?

The stock symbol (or ticker) of Reviva Pharmaceuticals Holdings Inc. is RVPH

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top